Cargando…
Coexistence of primary myelofibrosis and chronic lymphocytic leukaemia: treatment of two different diseases with one agent
Autores principales: | Burgstaller, S, Wimmer, S, Mayrbaeurl, B, Hoebling, W, Thaler, J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3255260/ https://www.ncbi.nlm.nih.gov/pubmed/22829155 http://dx.doi.org/10.1038/bcj.2011.18 |
Ejemplares similares
-
Ph-Negative Chronic Myeloproliferative Neoplasm (Primary Myelofibrosis) – as One of the Reasons of the Budd-Chiari Syndrome
por: Sokolova, M., et al.
Publicado: (2012) -
The Coexistence of Chronic Lymphocytic Leukemia and Multiple Myeloma
por: Hangül, Ceren, et al.
Publicado: (2019) -
Erythrodermic psoriasis de novo versus skin lesions in chronic lymphocytic leukaemia
por: Słomiak-Wąsik, Anna, et al.
Publicado: (2020) -
Coexistence of BCR/ABL1-positive chronic myeloid leukemia and JAK2 V617F-mutated myelofibrosis successfully treated with dasatinib and ruxolitinib
por: Yi, Jun Ho, et al.
Publicado: (2019) -
Application of current prognostic models for primary myelofibrosis in the setting of post-polycythemia vera or post-essential thrombocythemia myelofibrosis
por: Tefferi, A, et al.
Publicado: (2017)